Wu Feng, Lin Xiao, Shan Su-Kang, Li Fuxingzi, Xu Feng, Zhong Jia-Yu, Guo Bei, Zheng Ming-Hui, Wang Yi, Mo Zhao-Hui, Yuan Ling-Qing
Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, China.
Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital, Central South University, Changsha, China.
Front Cell Dev Biol. 2020 Dec 7;8:594528. doi: 10.3389/fcell.2020.594528. eCollection 2020.
It was previously demonstrated that miR-199a-3p plays an important role in tumor progression; especially, its down-regulation in papillary thyroid cancer (PTC) is associated with cancer cell invasion and proliferation. In the present report, we investigated the mechanism involved in the down-regulation of miR-199a-3p in PTC and how miR-199a-3p regulates PTC invasion both and .
qRT-PCR and Western blot assays were used to determine the expression of the investigated genes. Bisulfite sequencing PCR was used to investigate miR-199a-3p methylation. The functions of miR-199a-3p were investigated by a series of and experiments.
Our results showed hypermethylation of the miR-199a-3p promoter, which resulted in decreased miR-199a-3p expression both in PTC cell lines and PTC tissues. DNA-methyltransferase 3a (DNMT3a), a target gene of miR-199a-3p, was increased both in PTC cell lines and PTC tissues, while 5-aza-2'-deoxycytidine (methyltransferase-specific inhibitor) or knock-down using DNMT3a Small-Interfering RNA could restore the expression of miR-199a-3p, and the over-expression of miR-199a-3p could decrease the expression of DNMT3a; this suggests that miR-199a-3p/DNMT3a constructs a regulatory circuit in regulating miR-199a-3p/DNMT3a expression. Moreover, gain- and loss-of-function studies revealed that miR-199a-3p is involved in cancer cell migration, invasion, and growth. Meanwhile, we found that RAP2a was also a direct target of miR-199a-3p, which might mediate the tumor-growth-inhibiting effect of miR-199a-3p. To further confirm the tumor-suppressive properties of miR-199a-3p, stable overexpression of miR-199a-3p in a PTC cell line (BCPAP cells) was xenografted to athymic BALB/c nude mice, resulting in delayed tumor growth . In clinical PTC samples, the expression of RAP2a and DNMT3a was increased significantly, and the expression of RAP2a was inversely correlated with that of miR-199a-3p.
Our studies demonstrate that an epigenetic change in the promoter region of miR-199a contributes to the aggressive behavior of PTC via the miR-199a-3p/DNMT3a regulatory circuit and directly targets RAP2a.
先前的研究表明,miR-199a-3p在肿瘤进展中发挥重要作用;特别是,其在甲状腺乳头状癌(PTC)中的下调与癌细胞的侵袭和增殖有关。在本报告中,我们研究了PTC中miR-199a-3p下调所涉及的机制,以及miR-199a-3p如何调节PTC的侵袭。
采用qRT-PCR和蛋白质免疫印迹分析来确定所研究基因的表达。亚硫酸氢盐测序PCR用于研究miR-199a-3p的甲基化。通过一系列功能获得和功能缺失实验研究miR-199a-3p的功能。
我们的结果显示miR-199a-3p启动子的高甲基化,这导致PTC细胞系和PTC组织中miR-199a-3p表达降低。DNA甲基转移酶3a(DNMT3a)是miR-199a-3p的靶基因,在PTC细胞系和PTC组织中均增加,而5-氮杂-2'-脱氧胞苷(甲基转移酶特异性抑制剂)或使用DNMT3a小干扰RNA敲低可恢复miR-199a-3p的表达,并且miR-199a-3p的过表达可降低DNMT3a的表达;这表明miR-199a-3p/DNMT3a在调节miR-199a-3p/DNMT3a表达中构建了一个调节回路。此外,功能获得和功能缺失研究表明,miR-199a-3p参与癌细胞的迁移、侵袭和生长。同时,我们发现RAP2a也是miR-199a-3p的直接靶标,这可能介导miR-199a-3p的肿瘤生长抑制作用。为了进一步证实miR-199a-3p的肿瘤抑制特性,将miR-199a-3p在PTC细胞系(BCPAP细胞)中的稳定过表达移植到无胸腺BALB/c裸鼠中,导致肿瘤生长延迟。在临床PTC样本中,RAP2a和DNMT3a的表达显著增加,并且RAP2a的表达与miR-199a-3p的表达呈负相关。
我们的研究表明,miR-199a启动子区域的表观遗传变化通过miR-199a-3p/DNMT3a调节回路导致PTC的侵袭行为,并直接靶向RAP2a。